Stock Club

This week, Emmet is joined by an absolute legend of investing — co-founder of The Motley Fool, David Gardner. David is here to discuss his new book, Rule Breaker Investing: How to Pick the Best Stocks of the Future and Build Lasting Wealth, and share a few kernels of wisdom with the Stock Club fanbase.

Way back in the 1990s, Emmet stumbled upon David and his “6 Traits of a Rule Breaker Stock,” which helped him find opportunities lik...

This week, Mike and Emmet venture onto the shores of the healthcare industry to identify some potential hundred-baggers.

Emmet breaks down Oscar Health, a stock often discussed by investors on X and Reddit. The company was founded to bring technological disruption to the health insurance market, particularly among providers and plans operating under the Affordable Care Act. It has solid revenue growth, narrowing losses, and a strong...

The Multibagger King returns to Stock Club. Chris Mayer, author of 100 Baggers: Stocks That Return 100-to-1 and How to Find Them, inspired the creation of our international portfolio, Nexus, which aims to uncover great investments on foreign shores. In this throwback episode, he talks to us about his own approach to international investing.

Tune in to hear about his favorite brokerages, the quantitative and qualitative metrics he va...

If you’re fatigued with the Magnificent Seven and their eye-watering valuations, maybe it’s time to look at some smaller market caps.

Pieter Slegers, founder of Compounding Quality, is back to discuss his new investing service, Tiny Titans. By focusing on small caps, an investor can outperform the market by about 4% a year. But by combining this with some of Slegers’ “Compounding Quality” characteristics, such as positive free cash ...

In 2023, you’d be hard-pressed to find a Wall Street analyst who wasn’t in love with Lululemon. The stock was a classic example of a long-term, buy-and-hold winner, with a strong brand, enviable profit margins, and plenty of expansion opportunities.

However, coming into 2025, the company’s façade started to crack, with revenue growth slowing to single digits and comparable in-store sales falling. It appears the American market may b...

This week, we bring you a debate every investor has had over the last year: Is Tesla still a buy?

Mike starts off by breaking down the brand’s difficulties in Europe, with sales sliding across markets—particularly in the Nordics, Germany, and France. Some of this can be attributed to Musk’s political antics, but Mike argues that a bigger concern is the automaker’s inability to maintain its moat. Tesla faces more competition in the E...

Mike and Emmet are back from Investicon with two phenomenal stock picks shared by the event’s expert panel.

Mike breaks down Chapters Group (ETR: CHG), a vertical market software acquirer modeled after Constellation Software. With ~98% customer retention, ~90% gross margins, and disciplined capital allocation, the business is scaling rapidly. Though not cheap, Compounding Quality’s Pieter Slegers believes its leadership and growth o...

We're discussing two very different stocks today on Stock Club. One is the hottest stock on the market and one of the few companies being absolutely transformed by AI. Up 500% in the last year and almost 50,000% since 2022, this one is something you can't miss.

The other is a European microcap that you've almost certainly never heard of. The stock is due for a turnaround with new franchises coming to the fore and ex...

Novo Nordisk faced another tough earnings season, with the stock falling 30% after it revised its growth guidance due to increased competition from Eli Lilly and the (now-illegal) compounders. This has brought the stock down to a tantalizing 12x earnings. Is this a great time to pick up shares, or are investors risking catching a falling knife? Novo is attempting to fend off the competition by launching its own direct-to-consumer W...

This week, Mike sits down with Emma Farrelly, a Qualified Financial Adviser (QFA) and Retirement Planning Adviser (RPA) from Future Financial Planning in Dublin.

Emma walks through what every twenty-something needs to know about saving for success, the risks of relying solely on property as an investment, and what auto-enrolment means for both employees and employers. She also gives her two cents on our sworn enemy — deemed disposal...

This week, Emmet is joined by legendary investor Chris Hill. Chris was one of the Motley Fool’s longest-standing employees, contributing 26 years of expertise and stock pitches. He was the host of the Motley Fool’s Money podcast, which began in 2009. Earlier this year, he launched Money Unplugged, where he interviews guests about their money stories, struggles, and financial insights.

Chris shares his favorite guest splurges and mon...

Mike is joined by Clem Chambers, financial journalist, author, and contributor to Forbes, Fox, and Wired.

Clem is a self-described contrarian investor who seeks opportunities in inefficient markets. Tune in to hear his breakdown of why the U.K. stock market has fallen behind but is still a great place to find compounding stocks.

Later, Clem discusses the opportunity he sees in Intel. Despite being left behind by Nvidia, Intel’s manuf...

The IPO market has been a barren wasteland since the carefree days of 2020. But this week, we bring you an IPO that might actually be worth a look.

Figma has released its hotly anticipated S-1, revealing a business firing on all cylinders—with double-digit revenue growth, a 132% net dollar retention rate, and, most notably, profitability. The company now hopes to extend its land-and-expand sales model beyond the UI/UX space, though ...

Anne Marie and Mike are back and they are here to pitch two big name stocks trading on the cheap.

First up: Novo Nordisk. The Ozempic darling soared in 2024, but tough competition from Eli Lilly and a tumultuous relationship with Hims & Hers has left this pharmaceutical in the bin. Mike goes over its latest troubles but reminds us that it’s a market leader in a rapidly expanding market. Should you pick up this discounted giant? ...

This week, we continue our run-up to Investicon with Anthony Sheehy.

Anthony Sheehy is the owner and co-founder of several pioneering brands in the Irish whiskey industry, including the world’s first Irish whiskey auction platform. His expertise spans the industry—from warehousing, logistics, and sourcing to tourism, marketing, and investment.

He’s here to break down everything you need to know about whiskey investing, from finding a...

This week, we continue our run-up to Investicon with Pieter Slegers.

Pieter is the founder of Compounding Quality, a leading investment newsletter with more than 425,000 subscribers. His mission is to educate and empower long-term investors by focusing on high-quality companies and timeless investing principles—and that’s exactly what he delivers in this week’s episode.

Alongside Emmet, Pieter breaks down Evolution AB and Kinsale Cap...

This week, Stock Club brings you an Investicon preview with Eric Bleeker from 24/7 Investing.

Eric is an expert in AI investing, the founder of the AI Investor Podcast, and one of Nvidia’s earliest proponents. He’s here to walk you through the current market outlook. While he doesn’t shy away from comparisons to the dot-com bubble, he still believes AI will be a life-changing addition to your portfolio.

Although AI-specific stocks ar...

The MyWallSt team has big news!

On 21 August 2025, we’re hosting Investicon live in Dublin at the historic Irish Stock Exchange.

We’ll be bringing our stock and ETF expertise to the stage, alongside a star-studded panel of experts across various investing specialties.

The group will cover everything from wealth preservation strategies to high-flying AI stocks—and even the emerging whiskey investment space. Our own Emmet Savage will be...

Bragging may be unbecoming, but Mike and Emmet are here to do just that.

As of this week, our international portfolio, Nexus II, is outperforming the S&P 500 by 20%. While macroeconomic uncertainty reigns in the U.S., international stocks are having a strong year. To celebrate, Mike walks you through the latest addition to Nexus II: Vitec Software Group.

It’s Swedish, growing rapidly, and resembles a young Constellation Software....